Journal for ImmunoTherapy of Cancer (Nov 2020)

54 Patient stratification using clinical proteomics – validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues

Michael Schirm,
Gwenaël Pottiez,
Rudolf Guilbaud,
Lorella Di Donato,
Maxim Isabelle

Affiliations

Michael Schirm: Caprion Biosciences, Montreal, Canada
Gwenaël Pottiez: Caprion Biosciences, Montreal, Canada
Rudolf Guilbaud: Caprion Biosciences, Montreal, Canada
Lorella Di Donato: Caprion Biosciences, Montreal, Canada
Maxim Isabelle: Caprion Biosciences, Montreal, Canada

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0054
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal